• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
≥ 50,000 results

Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al

Docket 1:22-cv-01648, Delaware District Court (Dec. 30, 2022)
Judge Richard G. Andrews, presiding, Judge Laura D. Hatcher
Patent - Abbreviated New Drug Application (ANDA)
Log in to see more
cite Cite Docket
Analyze

Allergan, Inc. et al v. Revance Therapeutics, Inc. et al

Docket 1:21-cv-01411, Delaware District Court (Oct. 1, 2021)
Judge Richard G. Andrews, presiding, Judge Laura D. Hatcher
Patent
Log in to see more
cite Cite Docket
Analyze

No. 532 SO ORDERED Granting 531 STIPULATION and Proposed Order extending time to respond to the Court's ...

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 532 (D.Del. Feb. 14, 2025)
Motion to Extend TimeGranted
Log in to see more
cite Cite Document
Analyze

No. 346 MEMORANDUM OPINION

Document Mallinckrodt Pharmaceuticals Ireland Limited et al v. Airgas Therapeutics LLC et al, 1:22-cv-01648, No. 346 (D.Del. Feb. 12, 2025)
Log in to see more
cite Cite Document
Analyze

No. 526 ORDER ON MOTION TO SEAL: The motion to seal (D.I. 385 ) is GRANTED in part and DENIED in part

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 526 (D.Del. Feb. 12, 2025)
Motion to SealPartial
Log in to see more
cite Cite Document
Analyze

No. 480 ORDER: On December 20, 2024, Plaintiffs shall file a 20-page opening brief addressing the law ...

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 480 (D.Del. Dec. 16, 2024)
Log in to see more
cite Cite Document
Analyze

No. 478

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 478 (D.Del. Dec. 3, 2024)

cite Cite Document
Analyze

No. 476

Document Allergan, Inc. et al v. Revance Therapeutics, Inc. et al, 1:21-cv-01411, No. 476 (D.Del. Nov. 27, 2024)

cite Cite Document
Analyze
1 2 3 4 5 ... >>